|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"nash p"
Showing items 1-10 of 10 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-10-28T07:11:15Z |
Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies
|
Combe B.; TSEN-FANG TSAI; Huffstutter J.E.; Sprabery A.T.; Lin C.-Y.; Park S.Y.; Kronbergs A.; Hufford M.M.; Nash P. |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study
|
van der Heijde D.; Strand V.; Tanaka Y.; Keystone E.; Kremer J.; Zerbini C.A.F.; Cardiel M.H.; Cohen S.; Nash P.; Song Y.-W.; Tegzová D.; Gruben D.; Wallenstein G.; Connell C.A.; Fleischmann R.; Hall S.; Nicholls D.; Rischmueller M.; Baker M.F.; Bessette L.; Cividino A.A.; Haraoui B.; Niall Jones H.; Keystone E.C.; Khraishi M.; Thorne J.; Birbara C.A.; Baraf H.S.B.; Bathon J.M.; Brodsky A.L.; Cush J.J.; Dikranian A.H.; Diri E.; Dura P.A.; Lohr K.M.; Fleischmann R.M.; Griffin R.M.; Halter D.G.; Hargrove J.K.; Bouda D.W.; Reddy Pasya S.K.; Hill G.L.; Jackson R.E.; Kafka S.P.; Kaine J.L.; Katzenstein P.L.; Kempf K.J.; Kolba K.S.; Kremer J.M.; Longley S.; Mathews S.D.; Milton A.C.; Misischia R.J.; Moorman H.A.; Moreland L.W.; Niemer M.W.; Palmer W.R.; Sayers M.E.; Schuette P.T.; Shamim T.; Shergy W.J.; Sikes D.H.; Silverfield J.C.; Siva C.; Taborn J.D.; Walsh B.T.; Wells A.F.; Wolfe S.M.; Adhikari P.; Amano K.; Bae S.-C.; Chandrashekara S.; Chopra A.K.; PING-NING HSU; Iwahashi M.; Kadel J.K.; Kawabe Y.; Koh E.-M.; Lan J.-L.; Lee S.-K.; Lin H.-Y.; Liou L.-B.; Liu M.-F.; Migita K.; Miyamoto T.; Miyasaka N.; Mori S.; Munakata Y.; Ohta S.; Park W.; Park S.-H.; Rao U.R.; Shim S.C.; Shobha V.; Takasaki Y.; Takeuchi T.; Tanaka Y.; Tohma S.; Tsai W.-C.; Ueki Y.; Veeravalli S.C.M.; Wagh S.; Yamanaka H.; Yoo B.; Batalov A.; Bichoversuska D.; Dvorak Z.; Goranov I.; Hrytsenko H.M.; Kopackova J.; Mosterova Z.; Oparanov B.; Petrov A.; Pokrzywnicka-Gajek I.; Povoroznyuk V.V.; Rosa J.; Ruzga Z.; Settas L.; Stanislavchuk M.A.; Tseluyko V.I.; Vitek P.; de Freitas Zerbini C.A.; Brenol J.C.T.; Cardiel-Rios M.H.; Escalante W.J.O.; Maldonado-Lopez M.C.; Jaller Raad J.J.; Hernandez J.D.M.; Jauregui E.A.; Keiserman M.W.; Melazzi A.C.C.; Pascual-Ramos V.; Pinto L.T.; Radominski S.C.; Ximenes A.C.; de Morales S.V.; the ORAL Scan Investigators |
| 中山醫學大學 |
2021 |
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
|
Nash, P; Mease, PJ; Fleishaker, D; Wu, J; Coates, LC; Behrens, F; Gladman, DD; Kivitz, AJ; Wei, JC; Shirinsky, I; Menon, S; Romero, AB; Fallon, L; Hsu, MA; Wang, CS; Kanik, KS |
| 臺大學術典藏 |
2020-10-22T07:27:50Z |
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
|
Okada M.; Kirkham B.; Nash P.; Nash P.;Kirkham B.;Okada M.;Rahman P.;Combe B.;Burmester G.-R.;Adams D.H.;Kerr L.;Lee C.;Shuler C.L.;Genovese M.;Ahmed K.;Alper J.;Barkham N.;Bennett R.E.;Garc?A F.J.B.;Alonso R.B.;Blumstein H.B.;Brooks M.S.;Burmester G.-R.;Cagnoli P.;Caldron P.H.;Cantagrel A.;Chen D.-Y.;Churchill M.A.;Jr, Codding C.E.;Combe B.;Deane P.M.G.;Del Giudice J.;Deodhar A.A.;Dhar R.K.;Dokoupilova E.;Egan R.M.;Everding A.;Gal?Ndez E.;Genovese M.;Goddard D.H.;Gottlieb A.;Goupille P.;Griffin R.M.;Gupta R.C.;Hall S.;Hatti K.;Howell M.P.;Huang Y.-H.;Jajoo R.;Janssen N.M.;Kiltz U.;Kivitz A.J.;Klein S.J.;Korkosz M.P.;Kotha R.;Kremer J.M.;Lue C.;De La Fuente J.L.M.;Marzo-Ortega H.;Masmitja J.G.;Mease P.J.;Meroni P.L.;Mueller E.C.;Nandagudi A.C.;Nash P.;Fern?Ndez-Nebro A.;Neuwelt C.M.;Orbai A.M.;Oza M.R.;Parks D.L.;Pattanaik D.;Rell-Bakalarska M.E.;Rosmarin D.;Roussou E.;Rychlewska-Hanczewksa A.I.;Sikes D.H.;Stack M.T.;Sunkureddi P.;Tahir H.;Tha?I D.;Tsen-Fang Tsai;Turkiewicz A.M.;Unger L.;Cabello R.V.;Wagner U.;Wei C.-C.;Wells A.F.;Youssef P.;Zielinska A.; Korkosz M.P.; Klein S.J.; Kiltz U.; Kivitz A.J.; Janssen N.M.; Rahman P.; Combe B.; Burmester G.-R.; Adams D.H.; Kerr L.; Lee C.; Shuler C.L.; Genovese M.; Ahmed K.; Alper J.; Barkham N.; Bennett R.E.; Garc?a F.J.B.; Alonso R.B.; Blumstein H.B.; Brooks M.S.; Burmester G.-R.; Cagnoli P.; Caldron P.H.; Cantagrel A.; Chen D.-Y.; Churchill M.A.; Jr, Codding C.E.; Combe B.; Deane P.M.G.; Del Giudice J.; Deodhar A.A.; Dhar R.K.; Dokoupilova E.; Egan R.M.; Everding A.; Gal?ndez E.; Genovese M.; Goddard D.H.; Gottlieb A.; Goupille P.; Griffin R.M.; Gupta R.C.; Hall S.; Hatti K.; Howell M.P.; Huang Y.-H.; Jajoo R.; Zielinska A.; Wells A.F.; Youssef P.; Kotha R.; Kremer J.M.; Lue C.; de la Fuente J.L.M.; Marzo-Ortega H.; Masmitja J.G.; Mease P.J.; Meroni P.L.; Mueller E.C.; Nandagudi A.C.; Nash P.; Fern?ndez-Nebro A.; Neuwelt C.M.; Orbai A.M.; Oza M.R.; Parks D.L.; Pattanaik D.; Rell-Bakalarska M.E.; Rosmarin D.; Roussou E.; Rychlewska-Hanczewksa A.I.; Sikes D.H.; Stack M.T.; Sunkureddi P.; Tahir H.; Tha?i D.; TSEN-FANG TSAI; Turkiewicz A.M.; Unger L.; Cabello R.V.; Wagner U.; Wei C.-C. |
| 中山醫學大學 |
2020 |
ETANERCEPT WITHDRAWAL AND RE-TREATMENT IN PATIENTS WITH INACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AT 24 WEEKS: RESULTS OF RE-EMBARK, AN OPEN-LABEL, PHASE IV TRIAL
|
Van den Bosch, F; Wei, JCC; Nash, P; Blanco, FJ; Graham, D; Zang, C; Arthur, E; Borlenghi, C; Vlahos, B; Deodhar, A |
| 中山醫學大學 |
2020 |
Predictors of Maintaining Inactive Disease After Etanercept Withdrawal, and Regaining Inactive Disease Status After Flare and Retreatment, in Adults with Non-radiographic Axial Spondyloarthritis: Results from RE-EMBARK
|
Van den Bosch, F; Wei, JCC; Blanco, F; Selema, P; Graham, D; Arthur, E; Tsekouras, V; Vlahos, B; Zang, CB; Deodhar, A; Nash, P |
| 中山醫學大學 |
2020 |
Efficacy Outcomes Following Etanercept Withdrawal by Sustained Remission Status in Patients with Nr-axSpA: Results from RE-EMBARK
|
van den Bosch, F; Nash, P; Wei, JCC; Blanco, F; Tsekouras, V; Zang, CB; Graham, D; Arthur, E; Selema, P; Vlahos, B; Deodhar, A |
| 中山醫學大學 |
2020 |
TOFACITINIB AS MONOTHERAPY FOLLOWING METHOTREXATE WITHDRAWAL IN PATIENTS WITH PSORIATIC ARTHRITIS PREVIOUSLY TREATED WITH OPEN-LABEL TOFACITINIB plus METHOTREXATE: A RANDOMISED, PLACEBO-CONTROLLED SUBSTUDY OF OPAL BALANCE
|
Nash, P; Coates, LC; Mease, PJ; Kivitz, A; Gladman, DD; Behrens, F; Wei, JCC; Fleishaker, D; Wu, J; Wang, C; Romero, AB; Fallon, L; Hsu, MA; Kanik, K |
| 臺大學術典藏 |
2018 |
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2
|
Genovese M.C.;Combe B.;Kremer J.M.;Tsen-Fang Tsai;Behrens F.;Adams D.H.;Lee C.;Kerr L.;Nash P.; Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. |
| 國立成功大學 |
2013-06 |
DEMOGRAPHICS, ORGAN INVOLVEMENT AND MEDICATIONS IN SLE PATIENTS FROM SIX COUNTRIES IN ASIA-PACIFIC
|
Jakes, R. W.; Navarra, S.; Jain, P.; Louthrenoo, W.; Bae, S. -C.; Hoi, A.; Kong, N. C. T.; Koolvisoot, A.; Lin, H. -Y.; Nash, P.; Weng, M. -Y. |
Showing items 1-10 of 10 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
